Lund, Sweden

Lars Goran Wistrand

This inventor holds 1 USPTO granted patent. Top assignee: Amersham Health as. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lars Goran Wistrand. Retrieved from https://idiyas.com/inventor/lars-goran-wistrand-xli2l3gw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Lars Goran Wistrand

Introduction

Lars Goran Wistrand is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of therapeutic agents, particularly through his innovative work on nitric oxide releasing chelating agents. His research has implications for treating various medical conditions, showcasing the importance of his inventions in the healthcare sector.

Latest Patents

Wistrand holds a patent titled "Nitric oxide releasing chelating agents and their therapeutic use." This patent focuses on chelating agents, specifically dipyridoxyl and aminopolycarboxylic acid-based chelating agents. These agents, when linked to nitric oxide releasing moieties, have been found effective in treating disorders associated with free radicals in the body. The compounds may be particularly useful in addressing reperfusion injuries and reducing the cardiotoxicity of anti-tumor agents such as anthracyclines and paclitaxel. He has 1 patent to his name.

Career Highlights

Wistrand has built a career at Amersham Health, where he has been able to apply his innovative ideas in a practical setting. His work has contributed to advancements in medical treatments, particularly in the area of chelation therapy. His expertise and dedication to research have made him a valuable asset in the field.

Collaborations

Throughout his career, Wistrand has collaborated with notable colleagues, including Jan Olof Gustav Karlsson and Hakan Malmgren. These collaborations have likely enhanced the scope and impact of his research, leading to more comprehensive solutions in therapeutic applications.

Conclusion

Lars Goran Wistrand's contributions to the field of chelating agents and their therapeutic uses highlight the importance of innovation in medicine. His work continues to influence the treatment of various disorders, demonstrating the vital role of inventors in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…